Increasing pneumococcal vaccination in patients with heart failure: a scalable public health strategy

• by Ahmad Mourad, Adrian F Hernandez

• October 14, 2025

Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure

• by Ramzi Ibrahim, Luke Dreher, Hussein Abdul Nabi, Juan Maria Farina, Eiad Habib, Hoang Nhat Pham, Min Choon Tan, Hussein A. Noureldine, Sammudeen Ibrahim, Mayurkumar Bhakta, Kwan Lee, Dan Sorajja, Win-Kuang Shen, Luis R. Scott, Chadi Ayoub, Reza Arsanjani, Hicham Z. El Masry

• May 26, 2026

Recognizing the Transition to Advanced Heart Failure Earlier

Despite major advances in guideline-directed medical therapy (GDMT), worsening heart failure continues to drive significant morbidity, repeat hospitalizations and healthcare utilization worldwide.

• by

• May 27, 2026

• 6 min

Functional consequences of diminished myocardial oxygen delivery per beat in experimental heart failure

• by Salman I. Essajee, Matthew J. Eden, Victoria E. Sturgess, Gregory M. Dick, Selina M. Tucker, Cooper M. Warne, C. Alberto Figueroa, Daniel A. Beard, Johnathan D. Tune

• May 19, 2026